ZOGENIX, INC.
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 97.7B | ||||||
| 41.43B | ||||||
| 32.85B | ||||||
| 29.33B | ||||||
| 15.47B |
